Related references
Note: Only part of the references are listed.Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Alexander C. Leeksma et al.
HAEMATOLOGICA (2021)
Frequency, variations, and prognostic implications of chromosome 14q32 deletions in chronic lymphocytic leukemia
Rachel A. Harris et al.
LEUKEMIA RESEARCH (2021)
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
Miguel Quijada-Alamo et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
Isabel Gonzalez-Gascon-y-Marin et al.
CANCERS (2021)
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
Claudia Perez-Carretero et al.
DIAGNOSTICS (2021)
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Miguel Quijada-Alamo et al.
BLOOD CANCER JOURNAL (2021)
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
Fary Diop et al.
HAEMATOLOGICA (2020)
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Miguel Quijada-Alamo et al.
LEUKEMIA (2020)
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
Stuart J. Blakemore et al.
LEUKEMIA (2020)
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Adalgisa Condoluci et al.
BLOOD (2020)
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
Claudia Perez-Carretero et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Neus Gimenez et al.
HAEMATOLOGICA (2019)
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
Elena Vendramini et al.
LEUKEMIA (2019)
DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains
Maria Hernandez-Sanchez et al.
EXPERIMENTAL HEMATOLOGY (2019)
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes
Hong Fang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders
Jose M. Bastida et al.
HAEMATOLOGICA (2018)
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders
Jose M. Bastida et al.
HAEMATOLOGICA (2018)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group
Damien Roos-Weil et al.
GENES CHROMOSOMES & CANCER (2018)
TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
Elias Campo et al.
HAEMATOLOGICA (2018)
Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation
Lijian Yu et al.
CLINICAL CANCER RESEARCH (2017)
Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naive chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion
Carol Lozano-Santos et al.
LEUKEMIA & LYMPHOMA (2017)
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
Miguel Quijada-Alamo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
Michael Hallek
LANCET ONCOLOGY (2016)
Controversial fluorescence insitu hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort
Matthew S. Davids et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Mutations driving CLL and their evolution in progression and relapse
Dan A. Landau et al.
NATURE (2015)
Genetic inactivation of TRAF3 in canine and human B-cell lymphoma
Kevin R. Bushell et al.
BLOOD (2015)
Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing
Yanming Feng et al.
GENETICS IN MEDICINE (2015)
14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma
Adrien Cosson et al.
GENES CHROMOSOMES & CANCER (2014)
Recurrent Chromosome Abnormalities Define Nonoverlapping Unique Subgroups of Tumors in Patients With Chronic Lymphocytic Leukemia and Known Karyotypic Abnormalities
Victor H. Jimenez-Zepeda et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients
S. Weissmann et al.
LEUKEMIA (2013)
NOTCH1 mutations in CLL associated with trisomy 12
Veronica Balatti et al.
BLOOD (2012)
Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations
Cristina Lopez et al.
GENES CHROMOSOMES & CANCER (2012)
NOTCH1 mutations in+12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of+12 CLL
Ilaria Del Giudice et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
Anna Skowronska et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice
C. R. Moore et al.
LEUKEMIA (2012)
Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia
Y. Hwang et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2011)
13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia
H. Parker et al.
LEUKEMIA (2011)
Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms
Lena Reindl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia
Gary Lu et al.
CANCER GENETICS AND CYTOGENETICS (2010)
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
T. Zenz et al.
LEUKEMIA (2010)
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
Jitka Malcikova et al.
BLOOD (2009)
Frequency of 5′IGH deletions in B-cell chronic lymphocytic leukemia
Fabiola Quintero-Rivera et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)
I. Nagel et al.
LEUKEMIA (2009)
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis
Francesco Cavazzini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia
E. Chapiro et al.
LEUKEMIA (2008)
Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine
E. Van Den Neste et al.
LEUKEMIA (2007)
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation
Ji Martin-Subero et al.
LEUKEMIA (2007)
Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events
Iwona Wlodarska et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL
H. Pospisilova et al.
LEUKEMIA (2007)
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia
C Mayr et al.
BLOOD (2006)
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia
GS Nowakowski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Share Paper
